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Abstract
Background: Experimental studies suggest that changes in brain ventricle size are key events in bacterial
meningitis. This study investigated the relationship between ventricle size, clinical condition and risk of poor
outcome in patients with bacterial meningitis.
Methods: Adult patients diagnosed with bacterial meningitis admitted to two departments of infectious diseases
from 2003 through 2010 were identified. Clinical and biochemical data as well as cerebral computed tomographic
images were collected. The size of the brain ventricles were presented as a Ventricle to Brain Ratio (VBR). Normal
range of VBR was defined from an age matched control group. A multivariate analysis was performed to identify
predictors of 30-day mortality.
Results: One hundred and seven patients were included. Eighty-one patients had a CT scan at the time of
diagnosis. VBR was identified as an independent risk factor of 30-day mortality, Mortality Rate Ratio: 6.03 (95 %
confidence interval: 1.61-22.64, p = 0.008) for highest versus lowest tertile. A VBR deviating more than 2 standard
deviations from the normal range was associated with increased mortality.
Conclusions: Brain ventricles are commonly subject to marked changes in size as a consequence of meningitis.
Increased brain ventricle size in the acute phase of bacterial meningitis was associated with increased mortality.
Background
Brain edema and hydrocephalus are severe clinical condi-
tions leading to impaired consciousness and reduced brain
function in patients suffering from bacterial meningitis.
Experimentally, changes in ventricular size have
been shown to be closely related to disease severity
and appear to be a significant event in meningitis
pathophysiology [1, 2]. Among adult patients with
bacterial meningitis, severe hydrocephalus is a clinical
endpoint with high risk of poor outcome [3, 4].
In meningitis, the loss of blood-brain-barrier integrity
leads to extracellular fluid accumulation and develop-
ment of a vasogenic brain edema [5–7]. Compromised
cerebral blood flow (CBF) autoregulation is observed in
the early stages of meningitis, resulting in a vulnerable
CBF dependent on the systemic blood pressure [8–11].
The phenomenon “Resistance to cerebrospinal fluid (CSF)
outflow” indicates decreased re-absorption of CSF and
therefore accumulation. This may, in extreme cases, cause
development of hydrocephalus with accompanying increase
of intracranial pressure (ICP) [12, 13].
As stated by the Kellie Monroe doctrine, increased
volume in brain tissue, CSF or vascular compartment will
result in an increased ICP and subsequently a decreased
volume in the other compartments. This equation becomes
apparent in the hydrocephalic brain where the ventricular
system is enlarged on behalf of brain tissue. Similarly, in
advanced stages of cerebral edema, a reduction or compres-
sion of the CSF spaces may be observed [14].
Hydrocephalus is diagnosed when extreme expansion of
the ventricles is observed and is often defined by Evans
ratio or the bi-caudate index (BCI) [15]. However, any
ventricle expansion challenging the adaptive capacity of
the brain and vascular compartment could have clinical
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implications and we believe that less pronounced changes
in ventricular size, not diagnosed as hydrocephalus by
radiological definitions, could be an important part of
meningitis pathophysiology. The present study aimed to
investigate the number of patients with bacterial meningi-
tis presenting with ventricle compression or expansion
and the association between ventricular dimensions and
outcome.
Methods
The study was conducted by retrospective data collection
of patients who were admitted or referred to two depart-
ments of infectious diseases in the capital region from 2003
through 2010.
Patients were identified through the initial CSF sample
with elevated leukocyte count in the biochemical databases
LABKA I and LABKA II (CSC Scandihealth Aarhus,
Denmark). Data on blood biochemistry were also acquired
from LABKA I and II. Clinical data was collected from
patient files, clinical data sheets, nurse registration files and
discharge records. Data on computer tomographic (CT)
images of the brain were collected from the radiological
databases WebPAX (Heart Imaging Technologies, Durham,
North Carolina, USA) and Web1000 (Agfa, Mortsel,
Belgium).
Inclusion criteria
Patients ≥16 years, admitted or referred to two Infectious
Diseases specialist departments with fever and clinical
symptoms of meningitis with headache, neck stiffness or
reduced consciousness, coma or seizures. The clinical diag-
nosis of bacterial meningitis was supported by one or more
of the following criteria:
1) CSF leukocyte >10 × 106 cell/l in combination with a
positive CSF culture or microscopy
2) CSF leukocyte >10 × 106 cells/L and positive blood
culture
3) CSF leukocyte count >100 × 106 cells/L and CSF
protein >2.2 g/L or CRP >80 mg/L.
4) CSF leukocyte count >100 × 106 cells/L in
combination with an otogenic focus.
Patients should have received an appropriate treatment
regimen (dosage of antibiotics and treatment period).
Exclusion criteria
Patients with age < 16 years or a primary admission to a
paediatric department. Patients diagnosed with viral menin-
gitis and encephalitis (either by PCR, intrathecal antibody
synthesis or clinically), fungal or parasitic infection, cerebral
abscess, nosocomial and post-surgical meningitis, primary
endocarditis, aseptic meningitis, cerebral autoimmune dis-
ease or neoplasia were excluded.
Patients identified with confirmed or suspected bacter-
ial meningitis according to these criteria should have
had one or more CT scans performed during the course
of disease to be included.
Clinical data
Patient data were collected independently by two medical
doctors to limit registration errors. Random cases were
reviewed by a third medical doctor to verify data. In cases
of disagreement files were reviewed again.
For each patient a datasheet was completed containing:
1) demographic information, 2) clinical values at the time
of lumbar puncture (LBP) including blood pressure, pulse
and temperature, 3) clinical status at presentation, 4)
patient co-morbidity (based on discharge records and diag-
nosis from previous admissions), 5) results from CSF and
blood biochemistry, 6) information on treatment (obtained
from patient files, prescription sheets or the Danish Medi-
cine Administration) and finally 7) patient outcome.
Clinical presentation
As a Glasgow Coma Score (GCS) was not available for all
included patients, level of consciousness on admission was
determined from patient files and expressed as a Clinical
Presentation Score (CPS): 1) comatose, 2) reduced con-
sciousness, agitation, lack of ability to communicate, 3)
drowsy, but able to communicate and 4) awake and alert.
Outcome
Outcome was assessed retrospectively and established by
available patient data from discharge or from the first
ambulatory visit 10 to 14 days after discharge. Outcome
was expressed according to the Glasgow Outcome Scale
(GOS) [16]: 1) death, 2) vegetative state, 3) severe disability,
4) moderate disability and 5) good recovery .
CT-imaging
All CT images were performed with patients in the
supine position, untilted, using the anatomical land-
marks of the scull base and vertex. Number and tim-
ing of CT scanning sessions were recorded for all
included patients. Patients were divided into age
groups (<30, 30–39, 40–49, 50–59, 60–69, 70–79 and
≥80) based on previously defined age-related changes
of brain parenchyma in a normal population [17, 18].
Patients were also divided by time of scanning into: 1)
patients who had a CT scan performed within 24 h of
diagnosis and 2) patients who had a CT scan per-
formed later in the course of disease.
Measurement of ventricle size
From each collected CT scan, two representative and
consecutive images, displaying the lateral ventricles at the
level of the thalamus and upwards, where chosen. This was
Sporrborn et al. BMC Infectious Diseases  (2015) 15:367 Page 2 of 9
done to reduce the influence of variations in placing of
slices and slice thickness around foramen of Monroe.
In imaging sessions with reduced slice thickness,
three images were selected. Using MIPAV (http://
mipav.cit.nih.gov/), a region of interest (ROI) was
drawn lining ventricles and closely adjacent to brain
cortex/cerebellum in each image calculating areas in
mm2 and thereafter a Ventricle to Brain Ratio (VBR,
see Additional file 1). The mean of the ratios from the
included images constituted the patients VBR. VBR
was measured by a person blinded to the clinical sta-
tus and outcome of the patient.
Control group
A control group of 115 individuals who had a brain CT
scan diagnose ‘normal brain’ was included. The control
group was recruited from the same population as the
included meningitis patients and consisted of patients who
had a CT scan performed due to e.g. headache, dizziness or
unexplained syncope, in order to rule out focal brain path-
ology. Controls were randomly selected by the responsible
radiologist (KS). Control group patients were evenly distrib-
uted in the age intervals:16–19, 20–29, 30–39, 40–49, 50–
59, 60–69, 70–79, 80–89 and >90 years (n = 13 in each
group except 20–29 years and 80–89 years where n = 12).
As for meningitis patients, age groups 16–19 and 20–29
(<30) as well as age 80–89 and >90 (>80) were pooled for
the final data analysis. Eight of the included controls had a
history of alcohol abuse. VBR was calculated as described
above and the results were implemented as our reference
for normal range of VBR.
VBR values two standard deviations (2SD) above or
below control group mean for each age interval was consid-
ered “pathological”. VBR values in-between +/− 2 SD were
considered to be within normal range.
Data analysis and statistics
Categorical variables were compared using χ2 statistics.
Differences in continuous values were tested with the
Mann-Whitney test. Mortality rate ratios (MRRs) with
95 % confidence intervals (CIs) were computed using Cox
proportional hazard regression analysis. Patients with a CT
scan performed within 24 h of diagnosis were included in a
univariate analysis to identify risk factors of 30-day mortal-
ity. Variables that were associated with mortality in the uni-
variate analysis at a significance level of p < 0.1 were
included in a multivariate analysis.
Additionally, outcome was compared between patients
with normal range VBR and patients with a pathological
VBR. The analysis was performed both among patients
who had a CT scan performed within 24 h of diagnosis
and among all included patients, regardless of time of
scanning.
Survival curves were constructed by the method of
Kaplan-Meier. Analyses were performed using SPSS
version 20.0 (SPSS Inc., Chicago, IL, USA) and Graph
Pad Prism version 5.0 (GraphPad Software Inc., La
Jolla, CA, USA). The study was approved by the
Danish Data Protection Agency and by the Danish
Health and Medicines Authority with record no.3-
3013-135/1/.
Results
Patient characteristics, Table 1
We identified 1211 unique patients ≥16 years of age with a
CSF cell count >10 × 106 cells/L. Of those, 155 patients met
the inclusion criteria. Four patients had had neurosurgical
or ear-nose-throat surgery and were excluded due to having
post-surgical meningitis. One patient could not be evalu-
ated due to missing patient files. Of 150 patients, 109 had
one or more CT scans during the course of hospitalization.
Two patients were excluded due to insufficient quality of
CT images.
Patient age distribution was as follows: <30 (n = 5), 30–
39 (n = 4), 40–49 (n = 12), 50–59 (n = 21), 60–69 (n = 29),
70–79 (n = 26) and ≥80 (n = 10).
Eighty-one patients had a CT scan performed in immedi-
ate relation to the diagnostic LBP (median −2 h before LBP
[−5 to 0 h]) and were included in the primary study ana-
lysis. Of the remaining 26 patients, one had the first CT
scan performed 72 h before diagnosis and 25 patients had
their first CT scan performed more than 24 h after diagnos-
tic LBP (median 85 h after LBP [51 to 149.5]). Only one
patient presented with an imminent risk of interventricular
obstruction due to a thalamic haemorrhage. The patient
did not survive.
In Table 1, characteristics are shown for patients with
a CT scanning performed in immediate relation to
admission (n = 81). Including all patients, (n = 107) the
most common etiologic agent was Streptococcus pneu-
moniae (42.0 %). Predisposing risk factors for infection
were present in 32.0 % of patients with alcoholism and
diabetes being the most common. Thirty-day study mor-
tality was 33.0 %.
Etiology – culture positive and negative cases
Among patients where a CT scan was performed within
24 h of admission we found no differences in CSF bio-
chemistry (leukocyte count, protein and glucose) compar-
ing culture positive to culture negative cases. CSF
leukocyte counts (106 cells/L), median 2724 [595 to 6985]
versus 1166 [463 to 3332], p = 0.2; CSF protein (g/L),
median 5.4 [2.7 to 8.3] versus 3.2 [1.8 to 4.6], p = 0.09; and
CSF glucose (mmol/L), median 0.5 [0.1 to 2.4] versus 1.7
[1.5 to 3.3], p = 0.08.
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Clinical presentation (CPS)
Among patients where a CT scan was performed within
24 h of admission, the CPS was significantly correlated to
GOS (Spearman Rank, rho = 0.24, p = 0.04). Among all
patients diagnosed with bacterial meningitis (n = 150) CPS
was also significantly correlated to GOS (Spearman Rank,
rho = 0.32, p = 0.0002).
Patients with CT imaging performed within 24 h of
admission had significantly lower CPS compared to patients
where a CT scan was never performed (p = 0.004).
Table 1 Characteristics of 81 patients with acute bacterial meningitis and CT imaging within 24 h of diagnosis according to 30-day
survival
All Survivors Non-survivors P
valueN = 81 N = 55 (68 %) N = 26 (32 %)
Age, years 64 (52–74) 62 (51–68) 73 (54–84) 0.006
Sex 0.059
Male, % 44 (54 %) 34 (62 %) 10 (38 %)
Female, % 37 (46 %) 21 (38 %) 16 (62 %)
Etiology 0.23
Streptococcus pneumoniae 43 (53 %) 28 (51 %) 15 (58 %)
Streptococcus sp. 6 (7 %) 2 (4 %) 4 (15 %)
Staphylococcus aureus 4 (5 %) 3 (5 %) 1 (4 %)
Listeria monocytogenes 2 (3 %) 1 (2 %) 1 (4 %)
Unknown 21 (26 %) 16 (29 %) 5 (19 %)
Other 5 (6 %) 5 (9 %) 0 (0 %)
Adjuvant steroid, % 0.08
No 28 (35 %) 15 (27 %) 13 (50 %)
Yes 52 (65 %) 39 (71 %) 13 (50 %)
Comorbidity 0.39
None 51 (63 %) 32 (58 %) 19 (73 %)
Alcoholism 13 (16 %) 8 (15 %) 5 (19 %)
Malignancy 5 (6 %) 5 (9 %) 0 (0 %)
Diabetes mellitus 5 (6 %) 4 (7 %) 1 (4 %)
Asplenia 4 (5 %) 4 (7 %) 0 (0 %)
Other immunosupp 1 (1 %) 1 (2 %) 0 (0 %)
Other 2 (3 %) 1 (2 %) 1 (4 %)
Change in mental status, % 61 (82 %) 39 (71 %) 22 (85 %) 0.20
Focal neurologic deficit, % 17 (24 %) 15 (27 %) 2 (8 %) 0.07
Seizures, % 5 (7 %) 4 (7 %) 1 (4 %) 1.0
Temperature, ° C, n = 64 38.9 (37.9-39.5) 38.8 (37.7-39.4) 39.0 (38.0-39.5) 0.49
MAP, mmHg, n = 64 102 (88–110) 103 (92–112) 94 (77–109) 0.18
White Blood Cell Count, 109/L, n = 64 17.1 (12.1-22.6) 17.9 (12.5-24.0) 15.7 (11.9-22.9) 0.29
Plasma C-reactive Protein, mg/L 227 (144–337) 238 (151–334) 192 (87–369) 0.51
CSF-leukocytes 2182 (523–6188) 1932 (488–5150) 2826 (561–7930) 0.43
CSF-protein, n = 55 4.9 (2.5-7.8) 3.3 (2.1-6.2) 6.3 (5.1-11.2) 0.001
CSF-glucose, n = 59 1.5 (0.1-2.9) 1.4 (0.1-3.3) 1.5 (0.1-2.4) 0.40
VBR 0.10 (0.07-0.14) 0.09 (0.07-0.13) 0.13 (0.10-0.15) 0.005
VBR 0.005
<0.08 27 (33 %) 24 (44 %) 3 (11 %)
0.08-1.2 25 (31 %) 17 (31 %) 8 (31 %)
>0.12 29 (36 %) 14 (25 %) 15 (58 %)
MAP mean arterial pressure, CSF cerebrospinal fluid, VBR ventricle to brain ratio
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Fig. 1 a Distribution of Ventricle to Brain Ratio in age groups. Patients (scatter plot) and controls (box and whiskers with box showing median and
quartiles and whiskers min. and max.). Horizontal lines indicate VBR-tertiles used for multivariate analysis. b Examples of Ventricle to Brain Ratio in patients
with bacterial meningitis. Normal range VBR (left) and VBR increased > 2SD (right) within each age interval
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These patients were also more often treated in an
intensive care ward (n = 44/81 versus n = 24/69, chi-
square, p = 0.02) and more often received respirator
treatment (n = 36/81 versus 19/69, p = 0.03).
Ventricle to brain ratio – VBR, definition of pathological
VBR, Fig. 1 and Table 2
VBR increased with age and the variation in VBR was
considerably greater in the age groups 70–79 years
and > 80 years. Therefore the relationship between out-
come and a pathological VBR was both performed in-
cluding and excluding age groups >70 years (see Table 2
and Fig. 1a) [17].
Values of VBR denoted “pathological”, respectively 2
SD above and below control group mean in each age
interval was: age 16–29 years (0.023 and 0.07), 30–39
(0.028 and 0.091), 40–49 (0.022 and 0.139), 50–59 (0.046
and 0.12), 60–69 (0.039 and 0.13), 70–79 (0.049 and
0.18) and >80 (0.071 and 0.19).
Among patients with a CT scan performed within
24 h of admission (n = 81), 28.4 % (n = 23/81) pre-
sented with a pathological VBR. Among patients with
a first CT scan performed more than 24 h after diag-
nosis (n = 26), 27.0 % (n = 7/26) had a pathological
VBR. Expansion of brain ventricles was observed in
25.0 % (n = 27/107) including all patients who had a
CT scan performed.
Patients presenting with a pathological VBR had a signifi-
cantly higher incidence of fatal outcome (GOS 1) compared
to patients with a VBR within normal range (Table 2).
Multivariate analysis of factors associated with 30-day
mortality, Table 3 and Fig. 2
Eighty-one patients with a CT scan performed in associ-
ation with the diagnostic LBP were included in the univari-
ate analysis. Thirty-day mortality was 32.0 % (n = 26/81).
Age, sex, corticosteroid treatment, CSF protein concentra-
tion and VBR were associated with 30-day outcome at a
significance level of p < 0.1. There was no significant differ-
ence in remaining parameters, see Table 1. The relationship
between VBR and survival is shown in Fig. 2.
Because CSF-protein was unavailable in 26 of 81 patients,
two multivariate models were performed. In model 1, age,
sex, adjuvant steroid and VBR were included. After adjust-
ment only VBR remained statistically significantly associ-
ated with 30-day outcome although both sex and steroid
treatment approached significance (Table 3). In model 2,
further adjustment was done for CSF protein. Here increas-
ing VBR and higher levels of CSF protein were each associ-
ated with an increased risk of 30-day mortality (Table 3).
Patients in the highest VBR tertile (>0.12) had a more than
eight time increase in mortality when compared to patients
with a VBR in the lowest tertile (<0.08) (MRR 8.78 (1.74-
44.36), p = 0.009). Risk of 30-day mortality increased 17 %
per 1 g/L increment of CSF protein. Adjuvant steroid treat-
ment was not associated with outcome in this model.
Discussion
We found increased mortality among patients who
presented with significantly enlarged or compressed
brain ventricles when compared to patients with a VBR
within normal range. The association between increasing
Table 2 Pathological ventricle to brain ratio and outcome
CT scan performed within 24 h of diagnosis (n = 81) Pathological VBR* Normal VBR** P-value
All age groups No 28 % (n = 23/81) 72 % (n = 58/81)
GOS 1 56.5 % (n = 13/23) 31.0 % (n = 18/58) 0.033
GOS 5 34.8 % (n = 8/23) 34.5 % (n = 20/58) 0.98
<70 years No 33 % (n = 17/52) 67 % (n = 35/52)
GOS 1 53.0 % (n = 9/17) 14.3 % (n = 5/35) 0.003
GOS 5 35.3 % (6/17) 42.9 % (n = 15/35) 0.66
All CT scans performed during admission (n = 107)
All age groups No 28.0 % (n = 30/107) 72.0 % (n = 77/107)
GOS 1 50.0 % (n = 15/30) 32.5 % (n = 25/77) 0.12
GOS 5 26.7 % (n = 8/30) 37.7 % (n = 29/77) 0.37
<70 years No 29.6 % (n = 21/71) 70.4 % (n = 50/71)
GOS 1 52.4 % (n = 11/21) 16.0 % (n = 8/50) 0.003
GOS 5 28.6 % (n = 6/21) 48.0 % (n = 24/50) 0.19
VBR ventricle to Brain Ratio, GOS Glasgow outcome scale
* −/+ 2SD from control group mean VBR for age
** Within 2SD of control group mean VBR for age
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VBR and increased mortality was significant in a multi-
variate regression analysis, thereby taking into account
both the increased mortality and variation in ventricle
size observed with increasing age. In agreement with
previous studies, the multivariate analysis also identified
an augmented CSF protein content as a mortality risk
factor in bacterial meningitis [19]. The level of CSF
protein is a marker of the degree of blood-brain-barrier
breakdown and may therefore be associated to both
augmented vasogenic brain edema and to reduced CSF
circulation and re-absorption caused by increased CSF
viscosity [12, 20]. This could ultimately be associated to
an increased risk of developing hydrocephalus [13].
The definition and classification of ‘hydrocephalus’ have
for many years been a subject of debate [15, 21] Tradition-
ally, hydrocephalus is diagnosed by use of single-point
linear measurements such as the Bi-caudate Index (BCI)
[22] or the Evans Ratio [23] although the reliability of these
methods have been questioned [24]. We did not observe
any cases of inter-ventricular obstruction and expansion
was therefore believed to involve all parts of the ventricular
system. As previously documented, a VBR determined from
consecutive slices would provide a more accurate measure
of ventricular changes than BCI or Evans ratio [25].
Our demonstration of plateau phases of ventricular space
in age intervals - relatively constant up to the age of 60 and
markedly increased in older individuals - is in accordance
with previous findings [17]. Increasing ventricular size is a
common finding with advancing age and the increased
variance observed is likely due to accumulated brain tissue
loss caused by age, infarctions, dementia, alcohol abuse and
maybe psychiatric disease [26–28]. Due to variation, our
definition of a pathological VBR was conservatively based
on standard deviations calculated from the included control
group, merely confirming the impact of VBR on outcome.
The wide normal distribution increased the risk of regard-
ing patients, in fact suffering from a state of hydrocephalus,
and the predefined lower VBR limit is however likely to
reflect only severe cortex and white matter edema. This
hypothesis is supported by our finding of a stronger
association between pathologically increased VBR and
lethal outcome among patients below 70 years of age.
The combination of both enlarged and compressed ventri-
cles as pathological was performed since both entities are
associated with ICP changes and clinical deterioration.
Increased ICP is also what has recently been proposed by
Glimåker et al. to be involved in poor outcome from
bacterial meningitis. Repeated draining of CSF was their
Table 3 Multivariate analysis of predictors of 30-day mortality from acute bacterial meningitis
Multivariate model 1 Multivariate model 2
Unadjusted MRR (95 % CI) Adjusted MRR (95 % CI) P-value Adjusted MRR (95 % CI) P- value
Age, per year increment 1.05 (1.01-1.08) 1.03 (0.99-1.06) 0.17 0.99 (0.95-1.04) 0.66
Sex
Male 1.0 1.0 1.0
Female 2.31 (1.05-5.10) 2.30 (0.99-5.29) 0.051 2.77 (0.96-8.00) 0.061
VBR 0.036 0.029
<0.08 1.0 1.0 1.0
0.08-0.12 3.12 (0.83-11.75) 2.81 (0.70-11.28) 0.15 5.18 (0.88-30.53) 0.07
>0.12 5.97 (1.72-20.65) 6.03 (1.61-22.64) 0.008 8.78 (1.74-44.36) 0.009
Glucocorticosteroid
No 1.0 1.0 1.0
Yes 0.47 (0.22-1.01) 0.44 (0.19-1.03) 0.057 0.62 (0.20-1.96) 0.42
CSF-protein per g/L increment, n = 55 1.17 (1.07-1.28) - 1.17 (1.04-1.31) 0.008
MRR mortality rate ratio, CI confidence interval, VBR ventricle to brain ratio, CSF cerebrospinal fluid
Fig. 2 Survival from bacterial meningitis according to Ventricle to
Brain Ratio. Log-rank test: P = 0.004
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preferred method of reducing CSF pressure resulting in
reduced mortality. We believe that our results support the
findings by Glimåker et al.[29].
As would be expected, patients who had a CT scan
performed within 24 h of admission had lower clinical pres-
entation scores. Also, a higher proportion of these patients
were treated in intensive care and received respirator treat-
ment. Thus, they were likely to be sicker.
Even though we would expect the prognostic value of
VBR to be evaluated in association with the clinical appear-
ance of the patient, we did not detect any closer association
in the outcome analysis. We believe that the reason may
very well be that our retrospectively assessed clinical pres-
entation score was too crude and that the patients, where a
CT scan was performed within 24 h of admission, already
presented very low scores.
Mortality in the present study was higher than in other
recent studies [4, 30]. We believe this is to be expected
since our patient population was considerably older and
had much higher incidence of immunosuppressive co-
morbidity (i.e. alcoholism, diabetes, and malignancy) com-
pared to previous studies [31]. Both age and co-morbidity
have previously been shown to be poor prognostic factors
[31]. Furthermore, our patients with culture-confirmed
bacterial meningitis represented pathogens with the most
severe outcomes (streptococci and staphylococci) whereas
we had no cases of meningitis caused by N. meningitidis
which otherwise represent an infection with a fairly good
prognosis [16, 28, 29]. One of the hospitals included in
our study is a referral unit for patients with meningitis.
This is likely to have influenced the number of patients
with a complicated CNS infection and the relatively high
incidence of ventricle expansion. The true incidence of
hydrocephalus is however difficult to estimate, since previ-
ous studies have used different radiological definitions of
hydrocephalus, presumably diagnosing only severe hydro-
cephalus as a clinical or imaging endpoint. Only one other
study [3] has, to our knowledge, measured ventricular size
unanimously in all patients and they present results very
similar to ours. These numbers are much higher com-
pared to studies where ventricle size was only assessed in
patients with symptoms of increased ICP [4, 11, 30].
Forty patients had more than one CT scan during the
course of disease. Ideally, these patients could have acted as
their own controls, but unfortunately, the uneven timing of
the imaging sessions made interpreting the time related
variations in VBR speculative. Furthermore, repeated CT
imaging was performed in patients with clinical deterior-
ation or lack of improvement and not among patient with
good recovery.
The major limitation of our study is the retrospective
collection of data. Important clinical and biochemical data
from admission was therefore incomplete. As previously
mentioned our Clinical Presentation Score was rather crude
and GOS could only be retrospectively assessed. The retro-
spective design did not allow us to further evaluate the
pathophysiology behind the phenomenon of ventricle
expansion. Resistance to CSF out-flow could be involved,
and since ventricle expansion seem to develop irrespective
of bacterial pathogen, host physiology or the inflammatory
process itself may be responsible. Measuring CSF opening
pressure is not routine in Denmark and this otherwise very
relevant parameter therefore not available.
Our inclusion criteria may be considered to be wider
than other clinical studies. However, our baseline data
and number of culture negative cases are very similar to
previous studies. Furthermore, inclusion of patients from
a population with high levels of immunosuppressive co-
morbidity could result in a significant bias if only CSF
leukocyte count was evaluated. We did instead include
c-reactive protein, that has been shown to be very sensi-
tive as a supplemental parameter in order to differentiate
viral from bacterial meningitis [32].
Conclusions
The results of the present study show that enlarged brain
ventricles in patients with bacterial meningitis are associ-
ated with increased mortality. More subtle changes in
ventricle size other than frank hydrocephalus seem to be of
clinical importance. Thus, serial brain imaging with estima-
tion of ventricle expansion may therefore be useful support-
ing the clinical staging and prognosis of patients suffering
from this disease. Possible treatment strategies following
radiological suspicion of ventricle expansion in combin-
ation with clinical deterioration are limited due to the lack
of evidence for many of these strategies - being medical or
surgical treatments directed at reducing ICP.
Further research is needed to investigate the patho-
physiology behind increasing ventricular size in order to
elucidate whether ventricle enlargement - or the disease
mechanism allowing ventricles to expand - are critical
steps in the course of disease in bacterial meningitis.
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